View ValuationNeurones 향후 성장Future 기준 점검 2/6Neurones (는) 각각 연간 9.5% 및 4.9% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 9.4% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 14.4% 로 예상됩니다.핵심 정보9.5%이익 성장률9.39%EPS 성장률IT 이익 성장14.2%매출 성장률4.9%향후 자기자본이익률14.41%애널리스트 커버리지Low마지막 업데이트07 May 2026최근 향후 성장 업데이트공시 • Nov 08Neurones S.A. Provides Earnings Guidance for the Full Year 2025Neurones S.A. provided earnings guidance for the full year 2025. For the year, the group is now targeting annual revenues in excess of €850 million and operating profit of at least 8% .공시 • May 17Neurones S.A. Provides Earnings Guidance for the Year 2024Neurones S.A. provided earnings guidance for the year 2024. For the period, the company forecasts close to €800 million in revenues, operating profit of around 9.5%.공시 • Nov 10Neurones S.A. Provides Earnings Guidance for the Year 2023Neurones S.A. provided earnings guidance for the year 2023. The company confirms its forecasts for 2023 as a whole: revenues of more than €730 million, operating profit of around 10%.공시 • Sep 07Neurones S.A. Provides Earnings Guidance for the Full Year 2023Neurones S.A. provided earnings guidance for the full year 2023. For the year, the company expects revenue of more than €730 million and operating profit of around 10%.공시 • May 11Neurones S.A. Provides Earnings Guidance for the Full Year 2023Neurones S.A. provided earnings guidance for the full year 2023. For the year, the company expects revenue of €730 million and operating profit of around 10%.모든 업데이트 보기Recent updatesDeclared Dividend • May 04Dividend increased to €1.40Dividend of €1.40 is 7.7% higher than last year. Ex-date: 10th June 2026 Payment date: 12th June 2026 Dividend yield will be 3.9%, which is higher than the industry average of 2.4%. Sustainability & Growth The dividend has increased by an average of 37% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 34% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Buy Or Sell Opportunity • Apr 28Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 11% to €35.45. The fair value is estimated to be €45.54, however this is not to be taken as a buy recommendation but rather should be used as a guide only. For the next 3 years, revenue is forecast to grow by 5.4% per annum. Earnings are also forecast to grow by 10% per annum over the same time period.공시 • Apr 28Neurones S.A., Annual General Meeting, Jun 04, 2026Neurones S.A., Annual General Meeting, Jun 04, 2026. Location: 205 avenue georges clemenceau, nanterre FranceBuy Or Sell Opportunity • Apr 13Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 16% to €35.70. The fair value is estimated to be €45.11, however this is not to be taken as a buy recommendation but rather should be used as a guide only. For the next 3 years, revenue is forecast to grow by 5.4% per annum. Earnings are also forecast to grow by 10% per annum over the same time period.Reported Earnings • Mar 13Full year 2025 earnings releasedFull year 2025 results: Revenue: €857.2m (up 5.8% from FY 2024). Net income: €52.1m (flat on FY 2024). Profit margin: 6.1% (down from 6.5% in FY 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.4% p.a. on average during the next 3 years, compared to a 6.4% growth forecast for the IT industry in the United Kingdom.공시 • Nov 08Neurones S.A. Provides Earnings Guidance for the Full Year 2025Neurones S.A. provided earnings guidance for the full year 2025. For the year, the group is now targeting annual revenues in excess of €850 million and operating profit of at least 8% .공시 • Nov 05Neurones S.A. to Report Fiscal Year 2025 Results on Mar 11, 2026Neurones S.A. announced that they will report fiscal year 2025 results on Mar 11, 2026Buy Or Sell Opportunity • Sep 25Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 15% to €39.20. The fair value is estimated to be €49.24, however this is not to be taken as a buy recommendation but rather should be used as a guide only. For the next 3 years, revenue is forecast to grow by 5.3% per annum. Earnings are also forecast to grow by 11% per annum over the same time period.Reported Earnings • Sep 13First half 2025 earnings releasedFirst half 2025 results: Revenue: €424.3m (up 5.4% from 1H 2024). Net income: €22.7m (down 7.3% from 1H 2024). Profit margin: 5.3% (down from 6.1% in 1H 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.3% p.a. on average during the next 3 years, compared to a 6.8% growth forecast for the IT industry in the United Kingdom.Upcoming Dividend • Jun 04Upcoming dividend of €1.30 per shareEligible shareholders must have bought the stock before 11 June 2025. Payment date: 13 June 2025. Payout ratio is a comfortable 60% and this is well supported by cash flows. Trailing yield: 2.8%. Lower than top quartile of British dividend payers (5.6%). In line with average of industry peers (3.1%).Board Change • May 07Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. No experienced directors. 6 highly experienced directors. 2 independent directors (5 non-independent directors). Independent Director Marie-Françoise Jaubert was the last independent director to join the board, commencing their role in 2011. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.공시 • Apr 29Neurones S.A., Annual General Meeting, Jun 05, 2025Neurones S.A., Annual General Meeting, Jun 05, 2025. Location: 205 avenue georges clemenceau, nanterre FranceBuy Or Sell Opportunity • Apr 08Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 3.2% to €45.70. The fair value is estimated to be €37.65, however this is not to be taken as a sell recommendation but rather should be used as a guide only.Reported Earnings • Mar 09Full year 2024 earnings releasedFull year 2024 results: Revenue: €810.4m (up 9.3% from FY 2023). Net income: €52.5m (up 6.3% from FY 2023). Profit margin: 6.5% (down from 6.7% in FY 2023). The decrease in margin was driven by higher expenses.공시 • Mar 06Neurones S.A. Proposes Dividend for 2024Neurones S.A. announced that att the Shareholders' Meeting on June 5, 2025, the Board will suggest paying a dividend of €1.3 per share for 2024 (compared with €1.2 the previous year).공시 • Sep 19+ 1 more updateNeurones S.A. to Report First Half, 2025 Results on Sep 10, 2025Neurones S.A. announced that they will report first half, 2025 results on Sep 10, 2025Buy Or Sell Opportunity • Aug 03Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 11% to €40.85. The fair value is estimated to be €51.19, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 15%. Revenue is forecast to grow by 8.0% in a year. Earnings are forecast to grow by 2.2% in the next year.Upcoming Dividend • Jun 05Upcoming dividend of €1.20 per shareEligible shareholders must have bought the stock before 12 June 2024. Payment date: 14 June 2024. Payout ratio is a comfortable 59% and this is well supported by cash flows. Trailing yield: 2.5%. Lower than top quartile of British dividend payers (5.6%). In line with average of industry peers (2.3%).공시 • May 17Neurones S.A. Provides Earnings Guidance for the Year 2024Neurones S.A. provided earnings guidance for the year 2024. For the period, the company forecasts close to €800 million in revenues, operating profit of around 9.5%.Declared Dividend • May 03Dividend of €1.20 announcedShareholders will receive a dividend of €1.20. Ex-date: 12th June 2024 Payment date: 14th June 2024 Dividend yield will be 2.7%, which is higher than the industry average of 2.4%. Sustainability & Growth The dividend has increased by an average of 35% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to remain steady over the next year, which should provide adequate earnings cover for the dividend.Buy Or Sell Opportunity • Apr 17Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 10% to €48.00. The fair value is estimated to be €39.38, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue is forecast to grow by 7.0% in a year. Earnings are forecast to grow by 10% in the next year.Buy Or Sell Opportunity • Mar 29Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 5.2% to €45.95. The fair value is estimated to be €38.16, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue is forecast to grow by 7.0% in a year. Earnings are forecast to grow by 10% in the next year.Reported Earnings • Mar 07Full year 2023 earnings releasedFull year 2023 results: Revenue: €741.2m (up 11% from FY 2022). Net income: €49.4m (up 12% from FY 2022). Profit margin: 6.7% (up from 6.6% in FY 2022). The increase in margin was driven by higher revenue.Buy Or Sell Opportunity • Mar 07Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 16% to €45.90. The fair value is estimated to be €38.23, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue is forecast to grow by 4.3% in a year. Earnings are forecast to grow by 4.2% in the next year.공시 • Nov 28+ 2 more updatesNeurones S.A. to Report Fiscal Year 2023 Results on Mar 06, 2024Neurones S.A. announced that they will report fiscal year 2023 results on Mar 06, 2024공시 • Nov 10Neurones S.A. Provides Earnings Guidance for the Year 2023Neurones S.A. provided earnings guidance for the year 2023. The company confirms its forecasts for 2023 as a whole: revenues of more than €730 million, operating profit of around 10%.Buying Opportunity • Oct 31Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 9.9%. The fair value is estimated to be €42.98, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has grown by 17%. Revenue is forecast to grow by 15% in 2 years. Earnings is forecast to grow by 19% in the next 2 years.Buying Opportunity • Oct 09Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 6.8%. The fair value is estimated to be €45.84, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has grown by 17%. Revenue is forecast to grow by 15% in 2 years. Earnings is forecast to grow by 19% in the next 2 years.Reported Earnings • Sep 08First half 2023 earnings releasedFirst half 2023 results: Revenue: €368.7m (up 13% from 1H 2022). Net income: €25.4m (up 15% from 1H 2022). Profit margin: 6.9% (up from 6.7% in 1H 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.7% p.a. on average during the next 3 years, compared to a 8.2% growth forecast for the IT industry in the United Kingdom.공시 • Sep 07Neurones S.A. Provides Earnings Guidance for the Full Year 2023Neurones S.A. provided earnings guidance for the full year 2023. For the year, the company expects revenue of more than €730 million and operating profit of around 10%.Upcoming Dividend • Jun 07Upcoming dividend of €1.10 per share at 2.8% yieldEligible shareholders must have bought the stock before 14 June 2023. Payment date: 16 June 2023. Payout ratio is a comfortable 60% and this is well supported by cash flows. Trailing yield: 2.8%. Lower than top quartile of British dividend payers (5.8%). Higher than average of industry peers (2.5%).공시 • May 11Neurones S.A. Provides Earnings Guidance for the Full Year 2023Neurones S.A. provided earnings guidance for the full year 2023. For the year, the company expects revenue of €730 million and operating profit of around 10%.Reported Earnings • Mar 11Full year 2022 earnings releasedFull year 2022 results: Revenue: €665.4m (up 15% from FY 2021). Net income: €44.3m (up 18% from FY 2021). Profit margin: 6.7% (up from 6.5% in FY 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 7.2% p.a. on average during the next 2 years, compared to a 14% growth forecast for the IT industry in the United Kingdom.공시 • Feb 09Neurones S.A. to Report Fiscal Year 2022 Results on Mar 08, 2023Neurones S.A. announced that they will report fiscal year 2022 results After-Market on Mar 08, 2023Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 5 highly experienced directors. 2 independent directors (5 non-independent directors). Independent Director Marie-Françoise Jaubert was the last independent director to join the board, commencing their role in 2011. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.공시 • Nov 12Neurones S.A., Annual General Meeting, Jun 08, 2023Neurones S.A., Annual General Meeting, Jun 08, 2023.공시 • Nov 11Neurones S.A. to Report First Half, 2023 Results on Sep 06, 2023Neurones S.A. announced that they will report first half, 2023 results on Sep 06, 2023Reported Earnings • Sep 09First half 2022 earnings releasedFirst half 2022 results: Revenue: €327.1m (up 13% from 1H 2021). Net income: €22.1m (up 21% from 1H 2021). Profit margin: 6.8% (up from 6.3% in 1H 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 7.2% p.a. on average during the next 3 years, compared to a 16% growth forecast for the IT industry in the United Kingdom.Upcoming Dividend • Jun 01Upcoming dividend of €1.00 per shareEligible shareholders must have bought the stock before 08 June 2022. Payment date: 10 June 2022. Trailing yield: 2.8%. Lower than top quartile of British dividend payers (4.8%). Higher than average of industry peers (2.4%).Reported Earnings • Apr 27Full year 2021 earnings releasedFull year 2021 results: Revenue: €579.9m (up 11% from FY 2020). Net income: €37.7m (up 22% from FY 2020). Profit margin: 6.5% (up from 5.9% in FY 2020). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 8.3%, compared to a 16% growth forecast for the industry in the United Kingdom.Board Change • Apr 27Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 1 experienced director. 5 highly experienced directors. 2 independent directors (5 non-independent directors). Independent Director Marie-Françoise Jaubert was the last independent director to join the board, commencing their role in 2011. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Mar 11Full year 2021 earnings: Revenues in line with analyst expectationsFull year 2021 results: Revenue: €579.9m (up 11% from FY 2020). Net income: €37.7m (up 22% from FY 2020). Profit margin: 6.5% (up from 5.9% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 8.3%, compared to a 18% growth forecast for the industry in the United Kingdom.Upcoming Dividend • Jun 02Upcoming dividend of €2.00 per shareEligible shareholders must have bought the stock before 09 June 2021. Payment date: 11 June 2021. Trailing yield: 0.7%. Lower than top quartile of British dividend payers (4.0%). Lower than average of industry peers (2.0%).Reported Earnings • May 03Full year 2020 earnings released: EPS €1.28 (vs €1.27 in FY 2019)The company reported a mediocre full year result with weaker profit margins, although earnings were flat and revenues improved. Full year 2020 results: Revenue: €524.5m (up 2.8% from FY 2019). Net income: €30.9m (flat on FY 2019). Profit margin: 5.9% (down from 6.0% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 3% per year.Reported Earnings • Mar 06Full year 2020 earnings releasedThe company reported a mediocre full year result with weaker profit margins, although earnings were flat and revenues improved. Full year 2020 results: Revenue: €524.5m (up 2.8% from FY 2019). Net income: €30.9m (flat on FY 2019). Profit margin: 5.9% (down from 6.0% in FY 2019). The decrease in margin was driven by higher expenses.Analyst Estimate Surprise Post Earnings • Mar 06Revenue beats expectationsRevenue exceeded analyst estimates by 1.2%. Over the next year, revenue is forecast to grow 5.0%, compared to a 9.7% growth forecast for the IT industry in the United Kingdom.이익 및 매출 성장 예측LSE:0GX2 - 애널리스트 향후 추정치 및 과거 재무 데이터 (EUR Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/202899269N/AN/A112/31/202795063N/AN/A112/31/202690457N/AN/A112/31/2025857526171N/A9/30/2025845516475N/A6/30/2025832516678N/A3/31/2025821526981N/A12/31/2024810537284N/A9/30/2024793515873N/A6/30/2024775484362N/A3/31/2024758494967N/A12/31/2023741495472N/A9/30/2023724495974N/A6/30/2023707486476N/A3/31/2023686465465N/A12/31/2022665444455N/A9/30/2022642434251N/A6/30/2022618414047N/A3/31/2022599404956N/A12/31/2021580385864N/A9/30/2021570375865N/A6/30/2021559365866N/A3/31/2021542335967N/A12/31/2020524316067N/A9/30/2020518306169N/A6/30/2020511286370N/A3/31/2020510305866N/A12/31/2019510315361N/A9/30/201950530N/A53N/A6/30/201950130N/A45N/A3/31/201949528N/A38N/A12/31/201849026N/A31N/A9/30/201848726N/A28N/A6/30/201848326N/A25N/A3/31/201848427N/A24N/A12/31/201748527N/A23N/A9/30/201747827N/A24N/A6/30/201747027N/A25N/A3/31/201745926N/A23N/A12/31/201644725N/A21N/A9/30/201643624N/A21N/A6/30/201642523N/A20N/A3/31/201641222N/A25N/A12/31/201539921N/A30N/A9/30/201538621N/A30N/A6/30/201537421N/A29N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: 0GX2 의 연간 예상 수익 증가율(9.5%)이 saving rate(3.4%)보다 높습니다.수익 vs 시장: 0GX2 의 연간 수익(9.5%)이 UK 시장(11.5%)보다 느리게 성장할 것으로 예상됩니다.고성장 수익: 0GX2 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.수익 대 시장: 0GX2 의 수익(연간 4.9%)이 UK 시장(연간 4.5%)보다 빠르게 성장할 것으로 예상됩니다.고성장 매출: 0GX2 의 수익(연간 4.9%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: 0GX2의 자본 수익률은 3년 후 14.4%로 낮을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YSoftware 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/20 10:09종가2026/05/20 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Neurones S.A.는 1명의 분석가가 다루고 있습니다. 이 중 1명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Alexandre PlaudCIC Market Solutions (ESN)
공시 • Nov 08Neurones S.A. Provides Earnings Guidance for the Full Year 2025Neurones S.A. provided earnings guidance for the full year 2025. For the year, the group is now targeting annual revenues in excess of €850 million and operating profit of at least 8% .
공시 • May 17Neurones S.A. Provides Earnings Guidance for the Year 2024Neurones S.A. provided earnings guidance for the year 2024. For the period, the company forecasts close to €800 million in revenues, operating profit of around 9.5%.
공시 • Nov 10Neurones S.A. Provides Earnings Guidance for the Year 2023Neurones S.A. provided earnings guidance for the year 2023. The company confirms its forecasts for 2023 as a whole: revenues of more than €730 million, operating profit of around 10%.
공시 • Sep 07Neurones S.A. Provides Earnings Guidance for the Full Year 2023Neurones S.A. provided earnings guidance for the full year 2023. For the year, the company expects revenue of more than €730 million and operating profit of around 10%.
공시 • May 11Neurones S.A. Provides Earnings Guidance for the Full Year 2023Neurones S.A. provided earnings guidance for the full year 2023. For the year, the company expects revenue of €730 million and operating profit of around 10%.
Declared Dividend • May 04Dividend increased to €1.40Dividend of €1.40 is 7.7% higher than last year. Ex-date: 10th June 2026 Payment date: 12th June 2026 Dividend yield will be 3.9%, which is higher than the industry average of 2.4%. Sustainability & Growth The dividend has increased by an average of 37% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 34% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Buy Or Sell Opportunity • Apr 28Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 11% to €35.45. The fair value is estimated to be €45.54, however this is not to be taken as a buy recommendation but rather should be used as a guide only. For the next 3 years, revenue is forecast to grow by 5.4% per annum. Earnings are also forecast to grow by 10% per annum over the same time period.
공시 • Apr 28Neurones S.A., Annual General Meeting, Jun 04, 2026Neurones S.A., Annual General Meeting, Jun 04, 2026. Location: 205 avenue georges clemenceau, nanterre France
Buy Or Sell Opportunity • Apr 13Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 16% to €35.70. The fair value is estimated to be €45.11, however this is not to be taken as a buy recommendation but rather should be used as a guide only. For the next 3 years, revenue is forecast to grow by 5.4% per annum. Earnings are also forecast to grow by 10% per annum over the same time period.
Reported Earnings • Mar 13Full year 2025 earnings releasedFull year 2025 results: Revenue: €857.2m (up 5.8% from FY 2024). Net income: €52.1m (flat on FY 2024). Profit margin: 6.1% (down from 6.5% in FY 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.4% p.a. on average during the next 3 years, compared to a 6.4% growth forecast for the IT industry in the United Kingdom.
공시 • Nov 08Neurones S.A. Provides Earnings Guidance for the Full Year 2025Neurones S.A. provided earnings guidance for the full year 2025. For the year, the group is now targeting annual revenues in excess of €850 million and operating profit of at least 8% .
공시 • Nov 05Neurones S.A. to Report Fiscal Year 2025 Results on Mar 11, 2026Neurones S.A. announced that they will report fiscal year 2025 results on Mar 11, 2026
Buy Or Sell Opportunity • Sep 25Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 15% to €39.20. The fair value is estimated to be €49.24, however this is not to be taken as a buy recommendation but rather should be used as a guide only. For the next 3 years, revenue is forecast to grow by 5.3% per annum. Earnings are also forecast to grow by 11% per annum over the same time period.
Reported Earnings • Sep 13First half 2025 earnings releasedFirst half 2025 results: Revenue: €424.3m (up 5.4% from 1H 2024). Net income: €22.7m (down 7.3% from 1H 2024). Profit margin: 5.3% (down from 6.1% in 1H 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.3% p.a. on average during the next 3 years, compared to a 6.8% growth forecast for the IT industry in the United Kingdom.
Upcoming Dividend • Jun 04Upcoming dividend of €1.30 per shareEligible shareholders must have bought the stock before 11 June 2025. Payment date: 13 June 2025. Payout ratio is a comfortable 60% and this is well supported by cash flows. Trailing yield: 2.8%. Lower than top quartile of British dividend payers (5.6%). In line with average of industry peers (3.1%).
Board Change • May 07Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. No experienced directors. 6 highly experienced directors. 2 independent directors (5 non-independent directors). Independent Director Marie-Françoise Jaubert was the last independent director to join the board, commencing their role in 2011. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
공시 • Apr 29Neurones S.A., Annual General Meeting, Jun 05, 2025Neurones S.A., Annual General Meeting, Jun 05, 2025. Location: 205 avenue georges clemenceau, nanterre France
Buy Or Sell Opportunity • Apr 08Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 3.2% to €45.70. The fair value is estimated to be €37.65, however this is not to be taken as a sell recommendation but rather should be used as a guide only.
Reported Earnings • Mar 09Full year 2024 earnings releasedFull year 2024 results: Revenue: €810.4m (up 9.3% from FY 2023). Net income: €52.5m (up 6.3% from FY 2023). Profit margin: 6.5% (down from 6.7% in FY 2023). The decrease in margin was driven by higher expenses.
공시 • Mar 06Neurones S.A. Proposes Dividend for 2024Neurones S.A. announced that att the Shareholders' Meeting on June 5, 2025, the Board will suggest paying a dividend of €1.3 per share for 2024 (compared with €1.2 the previous year).
공시 • Sep 19+ 1 more updateNeurones S.A. to Report First Half, 2025 Results on Sep 10, 2025Neurones S.A. announced that they will report first half, 2025 results on Sep 10, 2025
Buy Or Sell Opportunity • Aug 03Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 11% to €40.85. The fair value is estimated to be €51.19, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 15%. Revenue is forecast to grow by 8.0% in a year. Earnings are forecast to grow by 2.2% in the next year.
Upcoming Dividend • Jun 05Upcoming dividend of €1.20 per shareEligible shareholders must have bought the stock before 12 June 2024. Payment date: 14 June 2024. Payout ratio is a comfortable 59% and this is well supported by cash flows. Trailing yield: 2.5%. Lower than top quartile of British dividend payers (5.6%). In line with average of industry peers (2.3%).
공시 • May 17Neurones S.A. Provides Earnings Guidance for the Year 2024Neurones S.A. provided earnings guidance for the year 2024. For the period, the company forecasts close to €800 million in revenues, operating profit of around 9.5%.
Declared Dividend • May 03Dividend of €1.20 announcedShareholders will receive a dividend of €1.20. Ex-date: 12th June 2024 Payment date: 14th June 2024 Dividend yield will be 2.7%, which is higher than the industry average of 2.4%. Sustainability & Growth The dividend has increased by an average of 35% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to remain steady over the next year, which should provide adequate earnings cover for the dividend.
Buy Or Sell Opportunity • Apr 17Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 10% to €48.00. The fair value is estimated to be €39.38, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue is forecast to grow by 7.0% in a year. Earnings are forecast to grow by 10% in the next year.
Buy Or Sell Opportunity • Mar 29Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 5.2% to €45.95. The fair value is estimated to be €38.16, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue is forecast to grow by 7.0% in a year. Earnings are forecast to grow by 10% in the next year.
Reported Earnings • Mar 07Full year 2023 earnings releasedFull year 2023 results: Revenue: €741.2m (up 11% from FY 2022). Net income: €49.4m (up 12% from FY 2022). Profit margin: 6.7% (up from 6.6% in FY 2022). The increase in margin was driven by higher revenue.
Buy Or Sell Opportunity • Mar 07Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 16% to €45.90. The fair value is estimated to be €38.23, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue is forecast to grow by 4.3% in a year. Earnings are forecast to grow by 4.2% in the next year.
공시 • Nov 28+ 2 more updatesNeurones S.A. to Report Fiscal Year 2023 Results on Mar 06, 2024Neurones S.A. announced that they will report fiscal year 2023 results on Mar 06, 2024
공시 • Nov 10Neurones S.A. Provides Earnings Guidance for the Year 2023Neurones S.A. provided earnings guidance for the year 2023. The company confirms its forecasts for 2023 as a whole: revenues of more than €730 million, operating profit of around 10%.
Buying Opportunity • Oct 31Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 9.9%. The fair value is estimated to be €42.98, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has grown by 17%. Revenue is forecast to grow by 15% in 2 years. Earnings is forecast to grow by 19% in the next 2 years.
Buying Opportunity • Oct 09Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 6.8%. The fair value is estimated to be €45.84, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has grown by 17%. Revenue is forecast to grow by 15% in 2 years. Earnings is forecast to grow by 19% in the next 2 years.
Reported Earnings • Sep 08First half 2023 earnings releasedFirst half 2023 results: Revenue: €368.7m (up 13% from 1H 2022). Net income: €25.4m (up 15% from 1H 2022). Profit margin: 6.9% (up from 6.7% in 1H 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.7% p.a. on average during the next 3 years, compared to a 8.2% growth forecast for the IT industry in the United Kingdom.
공시 • Sep 07Neurones S.A. Provides Earnings Guidance for the Full Year 2023Neurones S.A. provided earnings guidance for the full year 2023. For the year, the company expects revenue of more than €730 million and operating profit of around 10%.
Upcoming Dividend • Jun 07Upcoming dividend of €1.10 per share at 2.8% yieldEligible shareholders must have bought the stock before 14 June 2023. Payment date: 16 June 2023. Payout ratio is a comfortable 60% and this is well supported by cash flows. Trailing yield: 2.8%. Lower than top quartile of British dividend payers (5.8%). Higher than average of industry peers (2.5%).
공시 • May 11Neurones S.A. Provides Earnings Guidance for the Full Year 2023Neurones S.A. provided earnings guidance for the full year 2023. For the year, the company expects revenue of €730 million and operating profit of around 10%.
Reported Earnings • Mar 11Full year 2022 earnings releasedFull year 2022 results: Revenue: €665.4m (up 15% from FY 2021). Net income: €44.3m (up 18% from FY 2021). Profit margin: 6.7% (up from 6.5% in FY 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 7.2% p.a. on average during the next 2 years, compared to a 14% growth forecast for the IT industry in the United Kingdom.
공시 • Feb 09Neurones S.A. to Report Fiscal Year 2022 Results on Mar 08, 2023Neurones S.A. announced that they will report fiscal year 2022 results After-Market on Mar 08, 2023
Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 5 highly experienced directors. 2 independent directors (5 non-independent directors). Independent Director Marie-Françoise Jaubert was the last independent director to join the board, commencing their role in 2011. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
공시 • Nov 12Neurones S.A., Annual General Meeting, Jun 08, 2023Neurones S.A., Annual General Meeting, Jun 08, 2023.
공시 • Nov 11Neurones S.A. to Report First Half, 2023 Results on Sep 06, 2023Neurones S.A. announced that they will report first half, 2023 results on Sep 06, 2023
Reported Earnings • Sep 09First half 2022 earnings releasedFirst half 2022 results: Revenue: €327.1m (up 13% from 1H 2021). Net income: €22.1m (up 21% from 1H 2021). Profit margin: 6.8% (up from 6.3% in 1H 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 7.2% p.a. on average during the next 3 years, compared to a 16% growth forecast for the IT industry in the United Kingdom.
Upcoming Dividend • Jun 01Upcoming dividend of €1.00 per shareEligible shareholders must have bought the stock before 08 June 2022. Payment date: 10 June 2022. Trailing yield: 2.8%. Lower than top quartile of British dividend payers (4.8%). Higher than average of industry peers (2.4%).
Reported Earnings • Apr 27Full year 2021 earnings releasedFull year 2021 results: Revenue: €579.9m (up 11% from FY 2020). Net income: €37.7m (up 22% from FY 2020). Profit margin: 6.5% (up from 5.9% in FY 2020). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 8.3%, compared to a 16% growth forecast for the industry in the United Kingdom.
Board Change • Apr 27Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 1 experienced director. 5 highly experienced directors. 2 independent directors (5 non-independent directors). Independent Director Marie-Françoise Jaubert was the last independent director to join the board, commencing their role in 2011. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Mar 11Full year 2021 earnings: Revenues in line with analyst expectationsFull year 2021 results: Revenue: €579.9m (up 11% from FY 2020). Net income: €37.7m (up 22% from FY 2020). Profit margin: 6.5% (up from 5.9% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 8.3%, compared to a 18% growth forecast for the industry in the United Kingdom.
Upcoming Dividend • Jun 02Upcoming dividend of €2.00 per shareEligible shareholders must have bought the stock before 09 June 2021. Payment date: 11 June 2021. Trailing yield: 0.7%. Lower than top quartile of British dividend payers (4.0%). Lower than average of industry peers (2.0%).
Reported Earnings • May 03Full year 2020 earnings released: EPS €1.28 (vs €1.27 in FY 2019)The company reported a mediocre full year result with weaker profit margins, although earnings were flat and revenues improved. Full year 2020 results: Revenue: €524.5m (up 2.8% from FY 2019). Net income: €30.9m (flat on FY 2019). Profit margin: 5.9% (down from 6.0% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 3% per year.
Reported Earnings • Mar 06Full year 2020 earnings releasedThe company reported a mediocre full year result with weaker profit margins, although earnings were flat and revenues improved. Full year 2020 results: Revenue: €524.5m (up 2.8% from FY 2019). Net income: €30.9m (flat on FY 2019). Profit margin: 5.9% (down from 6.0% in FY 2019). The decrease in margin was driven by higher expenses.
Analyst Estimate Surprise Post Earnings • Mar 06Revenue beats expectationsRevenue exceeded analyst estimates by 1.2%. Over the next year, revenue is forecast to grow 5.0%, compared to a 9.7% growth forecast for the IT industry in the United Kingdom.